Delivery Order SPE2DB24D3013-SPE2DB26FFFSF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on July 31, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OFEV 150 mg capsules (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.29 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on October 16, 2025, with a completion deadline of November 6, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of OFEV 150 mg capsules (60 count units) valued at $8,591. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The order is scheduled for completion by November 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of OFEV 150 mg capsules in quantities of 60 units. This firm fixed price delivery order, valued at $8,590.58, is scheduled for completion by October 20, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) under a firm fixed price arrangement. The award was made on September 17, 2025, with an ultimate completion date of October 8, 2025. This is a non-set-aside competitive award, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OFEV 150 mg capsules (60-count units) with a ceiling value of $8,590.58. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The contract is scheduled for completion by October 15, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OFEV 150 mg capsules (60-count units) with a contract ceiling value of $8,590.58. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The ultimate completion date is October 15, 2025, and performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OFEV 150 mg capsules (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 3, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement executed under AmerisourceBergen's existing Indefinite...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFSFDelivery Order
The Defense Logistics Agency awarded a $8,590.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on October 21, 2025, with completion targeted for November 12, 2025. This non-set-aside contract represents a delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves military and veteran healthcare systems through its comprehensive DLA contract vehicle. As a prime contractor with demonstrated capability to fulfill federal pharmaceutical supply requirements through open competition, AmerisourceBergen supplies a broad range of medications and medical commodities across multiple therapeutic domains. This delivery order exemplifies the company's role in supporting the Defense Health Agency and broader military healthcare programs through its flexible global pharmaceutical supply platform, which enables efficient distribution of both specialty and generic medications to federal healthcare beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 10/21/25 |